Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...
Dr. Kaustubh Mahamine, Dr. Ruchir Rastogi, Dr. B. Srihari, and Dr. Chandra Prakash Thakur — will share expert perspectives on the evolving management of Coronary Artery Disease in diabetic patients.
CT Insider on MSN
What is 'Ozempic 2.0'? New once-daily weight loss pills could be approved by FDA next year
Companies such as Novo Nordisk and Eli Lilly have plans to launch once-daily weight-loss pills in 2026, pending FDA approval, ...
Background Patients with single-ventricle physiology are often palliated with the Fontan operation, which may involve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback